Genetic mutations can lead to defects in glycosylation pathways, resulting in diseases such as CDGs. These disorders can manifest in a wide range of symptoms, including developmental delays, neurological issues, and immune deficiencies. Understanding the genetic basis of these mutations can help in the development of targeted therapies and diagnostic tools.